About this webinar:
This webinar presents the results of a blinded clinical validation study of Ibex’s AI algorithm, performed on an external dataset of prostate biopsies analyzed by independent pathologists at the University of Pittsburgh Medical Center (UPMC).
Pathologists are challenged to provide accurate and timely cancer diagnosis as the number of tests increases year-over-year. Ibex uses artificial intelligence (AI) to develop clinical-grade solutions that extend beyond cancer detection and support pathologists in all clinically significant features, including cancer proportion and perineural invasion, helping them meet reporting needs.
